Live Breaking News & Updates on Malignant Syndrome

Stay updated with breaking news from Malignant syndrome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)

Switching to UZEDY at four weeks after the last dose of once-monthly paliperidone palmitate provided the most comparable pharmacokinetic profile based on the relevant PK modeling data

Additional. ....

Nevada , United-states , Las-vegas , Christoph-correll , Eric-hughes , Invega-sustenna , Zucker-school-of-medicine , Teva-neuroscience-inc , Teva-pharmaceuticals , Teva-pharmaceutical-industries-ltd , Teva-at-psych-congress-elevate , Mental-health-services-administration

Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024

Nearly 98% of patients experience quality of life impact as a result of tardive dyskinesia including social, psychological, physical and recreational aspects of daily living

Data highlight for. ....

Nevada , United-states , Michigan , Richard-jackson , Las-vegas , Eric-hughes , Drug-administration , Abnormal-involuntary-movement-scale , National-alliance-on-mental-illness , Psych-congress-elevate-annual-meeting , Teva-pharmaceutical-industries-ltd , Teva-pharmaceuticals

Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)

U.S. FDA approves new one pill, once-daily AUSTEDO XR tablets

AUSTEDO XR offers more flexibility with the most once-daily doses of any vesicular monoamine transporter 2 inhibitor for effective. ....

Texas , United-states , Americans , Dell-faulkingham , Rakesh-jain , Clin-psychopharmacol , National-institute-of-mental-health , Texas-tech-university-school-of-medicine , Drug-administration , Teva-shared-solutions , Teva-neuroscience-inc , Teva-pharmaceutical-industries-ltd

Neurocrine Biosciences Announces CEO Succession Plan

Neurocrine Biosciences Announces CEO Succession Plan
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

California , United-states , United-kingdom , Kyle-gano , Los-angeles , Tanabe-pharma , Williamh-rastetter , Neurocrine-biosciences , Kylew-gano , Kevin-gorman , Nxera-pharma , Sosei-heptares

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical ...

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, ....

Ukraine , Miami , Florida , United-states , American , Cameron-radinovic-lee-roth , Juan-sanchez , Cellular-therapies-inc , Burns-mcclellan-inc , Exchange-commission , American-society-of-clinical-psychopharmacology , Corporate-communications